Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis

Area of Science:

• Neuroimmunology
• Molecular Biology
• Genetics

Background:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• Aberrant microRNA (miRNA) expression is implicated in MG pathogenesis, but mechanisms are unclear.

Purpose of the Study:

• To identify key genes regulated by miRNAs in myasthenia gravis.
• To elucidate the molecular mechanisms underlying MG pathogenesis.

Main Methods:

• Differential expression analysis of miRNAs and messenger RNAs (mRNAs) in MG.
• Pathway analysis to identify dysregulated biological processes.
• Network analysis to detect gene interactions and crosstalk.

Main Results:

• Six dysregulated pathways were identified in MG, with significant crosstalk among five.
• Five genes in the MAPK signaling pathway mediated crosstalk between the "synaptic long-term potentiation" pathway and others.
• Fourteen key miRNA-regulated genes were identified, with MAPK1 and RAF1 playing central roles (80% of crosstalk).
• Key genes were enriched in immune-related areas affected in MG.

Conclusions:

• This study reveals crucial miRNA-regulated genes and pathway interactions in MG pathogenesis.
• MAPK1 and RAF1 are identified as central players in MG-associated pathway crosstalk.
• The findings provide novel insights and potential therapeutic targets for myasthenia gravis.